Catalyst Biosciences Inc. (CBIO) Spiked Higher After Korean Approval

Catalyst Biosciences Inc. (CBIO) announced Tuesday morning that the Korean Ministry of Food and Drug Safety has approved its Investigational New Drug Application for CB 2679d/ISU304.

from RTT - Before the Bell http://ift.tt/2mPotfQ
via IFTTT